In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0019
Abstract: SOURCE CITATION Temesgen Z, Burger CD, Baker J, et al. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022;10:237-46. 34863332. read more here.
Keywords: supplemental oxygen; inpatients covid; oxygen lenzilumab; covid need ... See more keywords